HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coppertone’s 2013 Lineup Targets Parents, Tattooed Consumers

This article was originally published in The Rose Sheet

Executive Summary

Among Coppertone’s new launches for summer 2013 are Coppertone Kids Wacky Foam, a foaming sunscreen lotion designed to be easy to apply to active children, and Tattoo Guard, aimed at a population that may not be using sunscreen products.

You may also be interested in...



FDA Strengthens Sunscreen Testing And Label Requirements

As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.

IFRA Implements New Methodology With 49th Amendment To Fragrance Safety Standards

The International Fragrance Association has given its ingredient safety standards a major overhaul based on a new methodology that accounts for aggregate exposure and an updated Quantitative Risk Assessment model for dermal sensitization.

NIH Study Links Hair Dyes, Straighteners To Breast Cancer Risk; Causation Piece Remains Lacking

Analyzing data from around 47,000 women enrolled in its Sister Study, the National Institute of Environmental Health Sciences found that regular users of permanent hair dye were 9% more likely to develop breast cancer compared with less frequent users. The increased probability reached 60% for African American women who dye their hair every five to eight weeks. Industry and NGO EWG respond.

Topics

Related Companies

UsernamePublicRestriction

Register

RS018921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel